Factors Affecting Success of Vaginal Birth After Cesarean Section

Factors Affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals

Factors affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals

Study Overview

• Status: Not yet recruiting
• Conditions: Vaginal Delivery
• Intervention / Treatment: Other: chance for vaginal delivery.

Detailed Description

• Clinical data will be collected from the participants including demographic details such as age, maternal age, parity, BMI, gestational age based on last menstrual period or early ultrasound scans available.
• Full medical and surgical history, previous CS details as an indication, and previous complications.
• Patients' clinical abdominal and per vaginal examination on admission (cervical dilatation, effacement head station, and position).
• CTG attached on admission (to exclude fetal distress).
• Laboratory investigations that will be done before delivery and postpartum, Labor progress on the partogram will be assessed as regard duration of both first and second stages of labor if any instrumental delivery will be done.
• Radiology investigations such as US.
• Records for patients' vital signs, fetal cardiac activity during labor, vaginal bleeding, delivery notes, fetal weight, and 5 minutes APGAR score, and any recorded maternal or fetal complications.
• If failed VBAC: Causes of failure maternal and fetal outcomes will be recorded and immediate CS to be done

• Study Type: Observational
• Enrollment (Estimated): 1

Contacts and Locations

• Study Contact: Name: Nahla Rashwan ezzeldine, master; Phone Number: 01013774970; Email: nashwa_rashwan_post@med.sohag.edu.eg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

All patients admitted for vaginal delivery with previous lower segment cesarean section . Age from 20 to 40 years.Time interval more than 1.5 years from previous caesarean section.

Description

Inclusion Criteria:

• • Age from 20 to 40 years.

  • Time interval more than 1.5 years from previous caesarean section.
  • Single viable full-term pregnancy in vertex presentation.
  • Reactive cardiotocography (CTG) on admission.
  • Spontaneous labor onset.
  • Clinically adequate pelvis.
  • Single fetus
  • Average AFI fetus

Exclusion Criteria:

• • Women with previous upper segment cesarean section or hysterotomy scar.

  • Any obstetric complications such as fetal malpresentation, placenta previa, or medical disorders like diabetes mellitus or preeclampsia.
  • Presence of any signs and symptoms of scar dehiscence or ruptured uterus, known uterine fibroid or anomaly.
  • Suspected fetal macrosomia (weight more than 4 kg).
  • Multifetal pregnancy.
  • Parturient women who refused the trial of vaginal birth after caesarean section.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Group I: Successful VBAC group; Successful VBAC group whose take chance for vaginal delivery.	Other: chance for vaginal delivery.; chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy
Group II: Failed VBAC group; Failed VBAC group whose take chance for vaginal delivery.	Other: chance for vaginal delivery.; chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
successful vaginal delivery	successful vaginal delivery in patients who had delivered by Caesarean section in first pregnancy	From November 2024 to April 2025

Collaborators and Investigators

• Sponsor: Sohag University

Study record dates

Study Major Dates

• Study Start (Estimated): December 1, 2024
• Primary Completion (Estimated): May 1, 2025
• Study Completion (Estimated): May 1, 2025

Study Registration Dates

• First Submitted: November 7, 2024
• First Submitted That Met QC Criteria: November 7, 2024
• First Posted (Estimated): November 8, 2024

Study Record Updates

• Last Update Posted (Estimated): November 8, 2024
• Last Update Submitted That Met QC Criteria: November 7, 2024
• Last Verified: November 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: soh-Ned-15-10_9MS

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No